PLACEMENT AGENT SERIES B COMMON STOCK PURCHASE WARRANTGenetronics Biomedical Corp • September 12th, 2003 • Surgical & medical instruments & apparatus • New York
THIS IS TO CERTIFY THAT SCO SECURITIES LLC, or registered assigns (the “Holder”), is entitled, during the Exercise Period (as hereinafter defined), to purchase from Genetronics Biomedical Corporation, a Delaware corporation (the “Company”), the Warrant Stock (as hereinafter defined and subject to adjustment as provided herein), in whole or in part, at a purchase price of $0.75 per share, all on and subject to the terms and conditions hereinafter set forth.
PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT by and among Genetronics Biomedical Corporation, as Issuer and Seller and SCO Capital Partners LLC, ProMed Partners, L.P., SDS Merchant Fund, LP and the other parties named herein, as Purchasers with...Preferred Stock and Warrant Purchase Agreement • September 12th, 2003 • Genetronics Biomedical Corp • Surgical & medical instruments & apparatus • New York
PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (the “Agreement”) dated as of July 14, 2003, by and among Genetronics Biomedical Corporation, a Delaware corporation (the “Seller”), SCO Capital Partners LLC, ProMed Partners, L.P., SDS Merchant Fund, LP and each of the other persons listed on Schedule 1 hereto (each is individually referred to as a “Purchaser” and collectively, as the “Purchasers”).
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • September 12th, 2003 • Genetronics Biomedical Corp • Surgical & medical instruments & apparatus • New York
This Agreement is being entered into pursuant to the Preferred Stock and Warrant Purchase Agreement, dated as of the date hereof, by and among the Company and the Purchasers (the “Purchase Agreement”).
FINANCIAL CONSULTANT AGREEMENTFinancial Consultant Agreement • September 12th, 2003 • Genetronics Biomedical Corp • Surgical & medical instruments & apparatus • Nevada
This Financial Consultant Agreement (the “Agreement”) is made by and between GENETRONICS BIOMEDICAL CORPORATION, a Delaware corporation (“Company”) and CATALYST CAPITAL, LLC, a Nevada limited liability company (“Consultant”) on this 3rd day of October 2002.
Amendment to Financial Consultant AgreementGenetronics Biomedical Corp • September 12th, 2003 • Surgical & medical instruments & apparatus • Nevada
We refer to the financial consultant agreement (the “Agreement”) between Genetronics Biomedical Corporation (the “Company”) and Catalyst Capital LLC (the “Consultant”) dated October 3, 2002. All capitalized terms used herein but not defined in this amending agreement have the meanings given to them in the Agreement.
